Guobo Shen

No. 17, Block 3, Southern Renmin Road
Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

Structural basis of internal Vangl2 peptide recognition by the Dvl2 PDZ domain.

Structural basis of internal Vangl2 peptide recognition by the Dvl2 PDZ domain.

Journal: Molecular biomedicine

Published: June 02, 2026

Modification of a SARS-CoV-2 spike-RBD targeting nanobody for pH-dependent binding and its chromatographic engineering for purification of WT and variant S-RBDs with mild elution conditions.

Modification of a SARS-CoV-2 spike-RBD targeting nanobody for pH-dependent binding and its chromatographic engineering for purification of WT and variant S-RBDs with mild elution conditions.

Journal: International journal of biological macromolecules

Published: April 24, 2025

Neoantigen-driven personalized tumor therapy: An update from discovery to clinical application.

Neoantigen-driven personalized tumor therapy: An update from discovery to clinical application.

Journal: Chinese medical journal

Published: December 22, 2024

A recombinant protein vaccine induces protective immunity against SARS-CoV-2 JN.1 and XBB-lineage subvariants.

A recombinant protein vaccine induces protective immunity against SARS-CoV-2 JN.1 and XBB-lineage subvariants.

Journal: Signal transduction and targeted therapy

Published: November 24, 2024

Recombinant XBB.1.5 boosters induce robust neutralization against KP.2- and KP.3-included JN.1 sublineages.

Recombinant XBB.1.5 boosters induce robust neutralization against KP.2- and KP.3-included JN.1 sublineages.

Journal: Signal transduction and targeted therapy

Published: November 21, 2024

Therapeutic potential of tumor-associated neutrophils: dual role and phenotypic plasticity.

Therapeutic potential of tumor-associated neutrophils: dual role and phenotypic plasticity.

Journal: Signal transduction and targeted therapy

Published: August 29, 2024

Intranasal delivery of a subunit protein vaccine provides protective immunity against JN.1 and XBB-lineage variants.

Intranasal delivery of a subunit protein vaccine provides protective immunity against JN.1 and XBB-lineage variants.

Journal: Signal transduction and targeted therapy

Published: July 04, 2024

Inhibition of NLRP3 inflammasome activation by A20 through modulation of NEK7.

Inhibition of NLRP3 inflammasome activation by A20 through modulation of NEK7.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: June 12, 2024

Intranasal vaccine combining adenovirus and trimeric subunit protein provides superior immunity against SARS-CoV-2 Omicron variant.

Intranasal vaccine combining adenovirus and trimeric subunit protein provides superior immunity against SARS-CoV-2 Omicron variant.

Journal: Nature biomedical engineering

Published: February 11, 2024

The potential and promise for clinical application of adoptive T cell therapy in cancer.

The potential and promise for clinical application of adoptive T cell therapy in cancer.

Journal: Journal of translational medicine

Published: February 06, 2024

Controlled release of MIF siRNA and GDNF protein from a photocurable scaffold efficiently repairs spinal cord injury.

Controlled release of MIF siRNA and GDNF protein from a photocurable scaffold efficiently repairs spinal cord injury.

Journal: MedComm

Published: January 17, 2024

A chimeric adenovirus-vectored vaccine based on Beta spike and Delta RBD confers a broad-spectrum neutralization against Omicron-included SARS-CoV-2 variants.

A chimeric adenovirus-vectored vaccine based on Beta spike and Delta RBD confers a broad-spectrum neutralization against Omicron-included SARS-CoV-2 variants.

Journal: MedComm

Published: November 23, 2023

Showing 1-12 of 56

Last Updated: 09/26/2026